Tested Applications
| Positive WB detected in | HL-60 cells, HepG2 cells |
| Positive IHC detected in | human ovarian cancer Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
19701-1-AP targets CYP4F3 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | cytochrome P450, family 4, subfamily F, polypeptide 3 |
| Calculated Molecular Weight | 60 kDa |
| Observed Molecular Weight | 60 kDa |
| GenBank Accession Number | NM_000896 |
| Gene Symbol | CYP4F3 |
| Gene ID (NCBI) | 4051 |
| RRID | AB_2878599 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q08477 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CYP4F3, also named as LTB4H and CYPIVF3, belongs to the cytochrome P450 family. Cytochromes P450 are a group of heme-thiolate monooxygenases. CYP4F3 requires molecular oxygen and NADPH for the omega-hydroxylation of LTB4, a potent chemoattractant for polymorphonuclear leukocytes.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CYP4F3 antibody 19701-1-AP | Download protocol |
| WB protocol for CYP4F3 antibody 19701-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CYP4F3 Polyclonal antibody (Cat# 19701-1-AP) has 2 total citations. One appeared in J Cancer Res Clin Oncol, studying probiotic therapy's protective effect on gut microbiota and ω-oxidation activation after ovarian cancer surgery in mice. The other was published in Nature, investigating how mitochondrial fission factor senses and governs ferroptosis in human samples. Both citations used the antibody for Western blot (WB), spanning research fields of oncology, gut microbiology, and mitochondrial biology/ferroptosis.
| Species | Application | Title |
|---|---|---|
J Cancer Res Clin Oncol The protective effect of probiotic therapy on gut microbiota and the activation of ω-oxidation after ovarian cancer surgery. | ||



